MyFinsight
Home
Blog
About
Contact
Download
Download image
Change in fair value of
contingent earnout...
$44,422K
Inventory
-$20,313K
something is missing
$50,385K
Purchase of property and
equipment
-$670K
Change in fair value of
derivatives
-$9,666K
Inventory reserve
$1,626K
Accounts receivable
-$905K
Finance lease
obligation
-$628K
Amortization of debt discount
$282K
Operating lease
obligation
$44K
Proceeds from the
issuance of common...
$18,676K
Payments of finance lease
principal
-$2,157K
Net cash used in
operating activities
$53,814K
Net cash provided by
financing activities
$19,007K
Net cash used in
investing activities
$670K
Canceled cashflow
$24,072K
Canceled cashflow
$52,211K
Net increase
(decrease) in cash, cash...
$73,491K
Non-cash interest
expense
-$6,446K
Accounts payable
-$5,496K
Stock-based compensation
expense
-$4,113K
Depreciation expense
-$2,645K
Prepaid expenses and
other current assets
$1,878K
Net (loss) income
-$1,590K
Amortization expense
-$1,122K
Accrued expenses
-$738K
Non-cash operating lease
costs
-$44K
Proceeds from the
issuance of common...
-$47,000K
Proceeds from the
issuance of common...
-$5,155K
Proceeds from the
exercise of stock options
-$56K
Back
Back
Cash Flow
source: myfinsight.com
Humacyte, Inc. (HUMAW)
Humacyte, Inc. (HUMAW)